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Endovascular repair of abdominal aortic
aneurysms has been shown to reduce length of hos-
pitalization, intensive care unit requirements, and
operative morbidity.1,2 The technique also reduces
recovery times for patients and allows an earlier
return to normal activities. This method of repair
offers the potential for a significant improvement in
wound morbidity for patients undergoing repair of
an abdominal aortic aneurysm, but a single or bilat-
eral groin incision is usually required. The natural
extension of this limited access approach is a totally
percutaneous approach to the repair of abdominal
aortic aneurysms. By using a modification of the
technique with a currently available percutaneous
closure device (Prostar, Perclose, Redwood City,
Calif),3,4 we have been able to perform percuta-
neous endovascular exclusion of abdominal aortic
aneurysms with large-caliber device-introduction
systems. This study assessed the initial experience
with this completely percutaneous approach.
MATERIAL AND METHODS
All endovascular aortic stent-graft procedures
performed with the AneuRx (Medtronic, Sunnyvale,
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Calif) aortic stent graft were identified from a
prospectively collected endovascular surgery reg-
istry. Of this group of patients, those who under-
went an attempted placement of this device with a
percutaneous technique were separately identified.
All patients had the standard accepted indications
for abdominal aortic aneurysm repair and qualified as
candidates for placement of the stent-graft device,
according to a Food and Drug Administration-
approved investigational device protocol accepted by
the institutional review board of the Cleveland Clinic
Foundation. Initially, all patients were considered to
be candidates for the percutaneous technique. After
we gained some experience, patients with heavily cal-
cified, small iliac arteries were excluded from the
attempt at this technique.
Patients undergoing standard endovascular
aneurysm repair had open surgical exposure of the
common femoral artery below the inguinal liga-
ment, through either a longitudinal or oblique inci-
sion, depending on surgeon preference. The intro-
duction of the endovascular device was performed
through common femoral arteriotomy over preposi-
tioned, 0.035-in guidewires (Amplatz, Boston
Scientific, Watertown, Mass). Patients were systemi-
cally heparinized with 5000 units of heparin, and the
common femoral arteriotomy was repaired with
either an interrupted or running suture closure after
the completion of the endovascular repair.
Patients undergoing percutaneous endovascular
aneurysm repair had retrograde percutaneous arter-
ial access achieved with an 18-gauge needle, a
0.035-in guidewire, and an 8F sheath. Systemic
heparinization was performed with 5000 units of
heparin after femoral artery cannulation. The 8F
sheath was then exchanged for a 10F Prostar device
(Perclose), which was deployed with the sutures left
unfastened (Figs 1 and 2). When the site accessed
percutaneously was to be used for the insertion of
the contralateral limb (16F outer diameter), the
puncture site was then reaccessed by means of the
reinsertion of the guidewire through the closure
device lumen and the insertion of a 16F sheath over
the guidewire.
In patients undergoing the insertion of the main
body of the device (21F outer diameter) percuta-
neously, the wire was reinserted, and a second clo-
sure device was advanced over the wire. When the
device was in position to be deployed, it was rotated
45 degrees and deployed in this orientation. Sutures
from this second device were deployed between the
sutures deployed from the previous device. These
sutures were also left unfastened and were tagged
separately from the other set of sutures. In five
patients, a second guidewire was inserted, alongside
the initial guidewire, through the 8F sheath. In
these patients, the second Prostar device was then
inserted alongside the first guidewire. The guidewire
was then reinserted, and a 22F sheath was placed
over the guidewire. This large caliber sheath does
not have a typical hemostatic valve, but rather a
“pinch valve,” necessitating clamping of the flexible
Fig 1. Side view of Prostar device with needles deployed into the arterial wall.
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portion of the sheath when only the wire was in
place. When manipulation of catheters or wires was
performed, an 8F sheath was inserted within the
larger sheath to obtain hemostasis at the hub. After
the placement of the device and confirmation of the
results with angiography, the previously placed
sutures were vigorously irrigated to remove accumu-
lated thrombus. The sutures were then fastened
individually with a slipknot to allow individual clo-
sure of each suture onto the arterial entry site. When
hemostasis was adequate after fastening of the
sutures, a sterile dressing was placed over the entry
site. In several instances, moderate oozing was noted
from the access site. In those instances, the sutures
were passed through a red rubber catheter, and ten-
sion was placed on the sutures. A hemostat was then
used to maintain the tension on the sutures. A small
fragment of Surgicel (Johnson and Johnson,
Arlington, Tex) was placed beneath the catheter to
tamponade the bleeding and achieve adequate
hemostasis. Manual pressure was also held in these
instances for 10 to 15 minutes. The Surgicel was left
in place with the tamponading tourniquet for 1 to 2
hours, and the red rubber catheter was removed in
the recovery room.
When the Prostar device was unsuccessful in
closing the arterial entry site, surgical exposure of
the artery was undertaken. If wire access to the
artery had been maintained, the previously removed
sheath was reinserted, and hemorrhage was con-
trolled with placement of the sheath during the sur-
gical exposure. When wire access to the vessel had
been abandoned, manual pressure was held, when
necessary, while proximal and distal control of the
vessel was obtained. The arterial access site was then
closed by means of a standard surgical technique,
with either running or interrupted sutures. If neces-
sary, femoral artery repair or external iliac
endarterectomy was undertaken to improve the flow
to the limb. We currently maintain wire access to the
vessel until adequate hemostasis has been achieved.
As per the protocol for placement of this device,
all patients had contrast and noncontrast computed
tomography (CT) scans of the abdomen and pelvis
performed 1 month after the placement of the
endovascular graft. These scans included views of the
femoral artery in the groins, allowing the evaluation
of the artery for potential pseudoaneurysm formation.
Additionally, patients underwent a preoperative and
1-month postoperative evaluation of lower-extremity
arterial flow, with ankle brachial indices and pulse vol-
ume recordings. Clinical evaluation of incision sites
was also performed 1 month postoperatively.
Records of patients undergoing percutaneous
endovascular repair were retrospectively reviewed.
All patients underwent a preoperative examination
with spiral CT scanning, calibrated angiography, and
intravascular ultrasound scanning. The results of
these studies, with the operative notes of patients
who underwent percutaneous placement, were
reviewed to evaluate anatomic variables and opera-
tive events impacting the percutaneous technique
and its success or failure. Operative times and the
length of hospital stay were reviewed and compared
between the two groups. Differences were com-
pared with the use of the Student t test, and signifi-
Fig 2. Illustration showing the position of sutures with a single Prostar device in position.
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cance was ensured when the two-tailed P value was
less than .05.
RESULTS
Seventeen patients underwent an attempted per-
cutaneous placement of both the main body and
contralateral limb (13 cases) or the contralateral
limb alone (four cases) of an endograft device.
Introduction of the main body was not attempted in
four patients, because of the initial experience (one
patient) or small iliac diameters or severe iliac tortu-
osity (three patients). In all cases, the device was able
to be successfully deployed. The patients included
16 men and one woman, ranging in age from 62 to
93 years (mean age, 76.3 ± 7.8 years). 
Successful percutaneous placement of the main
body stent graft was achieved in eight of 13 cases
(61.5%), whereas percutaneous contralateral limb
placement was successful in 11 of 17 cases (64.7%;
Table I). In 13 patients in whom bilateral percutaneous
deployment was attempted, six attempts (46.2%) were
successful. Reasons for conversion to open groin inci-
sions included inadequate hemostasis (six cases),
iliofemoral dissection (four cases), device failure (one
case), and compromised distal flow (one case).
Operative times in the two groups of patients
and in the six patients in whom the main body and
the contralateral limb were successfully deployed
percutaneously are shown in Table II. Attempting
percutaneous access did not significantly shorten the
length of the procedure, although a trend toward a
reduction of operative time existed (P = .06). The
group with bilateral percutaneous success, however,
had significantly (P < .001) shorter operative times.
Four of the six patients with bilateral percuta-
neous success went home on the first postoperative
day. The other two patients were medically fit to go
home the next day, but remained in the hospital for
social reasons (one patient) and a psychiatric prob-
lem (one patient).
Table I. Iliac diameters and percutaneous success
Main attempt/ Main Contra attempt/ Contra 
Patient Age (y) Sex R iliac (mm) L iliac (mm) sheath size success Sheath size success Perclose
1 70 M CIA = 12.8 No data Y/22F Y Y/16F Y 8,10F SEQ
R, 10 L
2 61 M EIA = 9.8 EIA = 8.5 Y/22F Y Y/16F Y 2 10F SEQ
R, 10 L
3 79 M EIA = 9.5 EIA = 9.2 Y/22F Y Y/16F Y 2 10F SBS
L, 10 R
4 81 M CIA = 14.0 CIA = 14.4 Y/22F N Y/16F N 2 10F R, 10F
L
5 92 M EIA = 6.2 CIA = 9.6 Y/22F N Y/22F N 2 10F SEQ 
R; 2 10F 
SEQ L
6 78 M CIA = 15.7 Tortuosity N/NA NA Y/16F Y 2 10F SEQ R
7 73 M EIA = 9.1 EIA = 9.4 Y/22F Y Y/NA N 2 10F SBS L,
10F R
8 84 M CIA = 20.9 EIA = 13.0 Y/22F Y Y/16F Y 2 10F SBS L,
10F R
9 73 M CIA = 13.3 CIA = 13.9 N/NA NA Y/16F Y 10F L
10 86 M EIA = 7.3 EIA = 8.6 Y/22F Y Y/16F N 2 10F SEQ 
L, 10F R
11 71 M No data No data Y/22F Y Y/16F Y 2 10F SEQ L,
10F L
12 83 M CIA = 12.0 CIA = 11.5 Y/24F N Y/16F Y 2 10F SBS L,
10F R
13 75 M CIA = 13.3 EIA = 10.5 Y/24F Y Y/16F Y 2 10F SEQ 
R, 10F L
14 69 M EIA = 6.7 EIA = 6.9 N/NA NA Y/16F Y 10F L
15 73 M EIA = 9.0 EIA = 8.8 Y/24F N Y/16F Y 2 10F SBS 
R, 10F L
16 65 F RCIA = Aneurysm No data N/NA NA Y/16F N 10F L
17 79 M EIA = 9.0 EIA = 8.8 Y/24F N Y/16F N 2 10F SEQ 
R, 10F L
Iliac diameters are given for available measurements. Perclose size is in French.
CIA, Common iliac artery; EIA, external iliac artery; F, female; L, left; M, male; N, no; NA, not applicable; R, right; SBS, side-by-side
placement; SEQ, sequential placement; Y, yes. 
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A detailed look at reasons for device failure has
proven helpful in revising our technique and inform-
ing others about the potential problems with this
technique (Table III). In the patients with inade-
quate hemostasis in particular, a number of specific
problems were noted. In three patients with bleeding
from the insertion of the main body of the device, a
24F sheath was used, because 22F sheaths were
unavailable at the time. In patient number 4, an
attempt was made to slip two separate knots down
over the sheath at the same time. In doing this, the
knots caught on each other and were unable to be
advanced down to the arterial access site. In patient
number 15, the needle and suture from a second
device pierced a suture from the first device, thereby
fixing it in place, and neither suture could be
advanced as a slipknot. In patient number 17, the
sutures did not have all the slack removed, the knots
caught on a loose suture within the wound, and
therefore, hemostasis could not be achieved. Because
of each of these situations, we have altered our tech-
nique in performing this procedure.
Vessel dissection has also been noted in several of
the patients. This problem has been noted primarily
in patients with smaller iliac arteries, especially small-
er external iliac arteries. This problem attains greater
significance with the larger (22F) sheaths. Because
of these findings, we have changed our technique
and our examination of patients for suitability for
this approach. Patients being considered for this
approach will undergo a preoperative examination of
the iliac vasculature with intravascular ultrasound
scanning, and diameters larger than 7 mm through-
out the iliac system are preferred.
Conversion to open groin incision was accompa-
nied by external iliac endarterectomy and common
femoral endarterectomy and prosthetic patch angio-
plasty in the two patients with vessel dissection and
by a femoral crossover graft in the final patient with
inflow problems. In patients in whom bleeding was
the cause of conversion, primary vessel repair was
able to be performed.
Nine of the 17 patients (53%) undergoing percu-
taneous repair required transfusion during their hos-
pitalization. In contrast, 28% of patients with open
surgical exposure of the femoral artery required a
transfusion. Of the eight patients in whom percuta-
neous access for either the main device or contralat-
eral limb failed, six patients (75%) required transfu-
sion. Of the nine patients who had successful percu-
taneous placement of part or all of the device, three
patients (25%) required transfusion.
No CT scan evidence of vessel abnormality was
noted in any of the patients at 1 month postoperative-
ly, and no evidence of pseudoaneurysm formation or
wound complications was found by means of the clin-
ical evaluation of the access sites and groin incisions.
DISCUSSION
Percutaneous repair of aortic aneurysms has
been described in animal models5 and in humans.6
However, previous reports dealt with small-caliber
devices; this is the first time on which devices with
diameters greater than 16F have been reported.
Additionally, in the only human study, an open sur-
gical approach to the artery was still used before clo-
sure.6 Limited access to the femoral artery has also
been described before.7 This approach, however,
still required surgical exposure of the femoral sheath
and parallels the closure noted in the study by
Papazoglou et al.6 In both of these studies, the
arteries were accessed percutaneously; however, a
limited dissection of the femoral sheath and a purse-
string suture of the femoral sheath were performed
to obtain closure of the access site. A recent clinical
report has documented the technique of using a per-
cutaneous suture closure device to seal large caliber
arterial access sites.8 In this report, the use of the
device was limited to 16F access sites, with good
technical results for adequate closure of the wound
(100% success). The patients in the current series
had a true attempt at complete percutaneous place-
ment and closure without open surgical exposure.
Despite large introducer sizes, percutaneous deploy-
ment of available aortoiliac endograft devices
appeared technically feasible with a novel modifica-
tion of the technique commonly used for percuta-
neous closure of smaller arterial defects.
Bleeding was the most common reason for the
failure of the percutaneous technique. Several of the
Table II. Comparison of operative times
Group Mean operative time (range)
Bilateral open femoral access (n = 82) 167 minutes (87-455 minutes)
Attempt at percutaneous access (n = 17) 138 minutes (80-334 minutes), P = .06
Bilateral percutaneous success (n = 6) 90 minutes (80-108 minutes), P < .001
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problems that led to bleeding have caused us to alter
our method of percutaneous closure. Sutures catch-
ing on other sutures as they were advanced has led
us to be much more careful in ensuring that all loops
of the sutures are pulled taut and out of the wound
before tying. Also, we now do not perform side-by-
side deployments of the device, in which two wires
are used within the artery and Prostar devices are
deployed, one over each wire. It has also become
clear that sutures that are wet are slicker and allow
easier slippage of the knot down to the access site.
This is especially true for some of the lengthier pro-
cedures and when blood has dried on the sutures.
Finally, three of the five bleeding failures occurred
when a 24F sheath was used. We are not currently
using sheaths with diameters this large to place the
graft percutaneously. The design of sheaths is in flux.
Improvements in sheath design can be expected to
have a beneficial impact on blood loss.
Vessel dissection with large sheaths and catheters
is a risk, whether open or closed vessel access is
attempted. Because the stent-graft deployment
devices lack a tapered tip, the contralateral limb
always requires the placement of a sheath. When
advancing the main body of the device percuta-
neously, the outer diameter of the device introduced
into the artery is increased by nearly 3F or 1 mm.
This is especially significant in patients with small
iliac vessels. We now use intravascular ultrasound to
measure the external iliac arteries and do not
attempt to place the larger (22F) sheath in vessels
smaller than 7 mm in diameter.
Another risk of endovascular abdominal aortic
aneurysm repair is distal embolization. One advan-
tage to open femoral access is the ability to occlude
the femoral artery distally and prevent embolization
during the manipulation of wires and catheters. One
of the 17 patients in this series experienced distal
embolization. This patient had significant external
iliac disease and a common iliac artery aneurysm on
the side of embolization. Embolization was only
noted after femorofemoral bypass grafting was per-
formed. Despite the large diameter of the sheaths,
which in part prevented embolization through occlu-
sion of the iliac vessels, patients with a large amount
of mural thrombus within their aneurysm may still be
better suited to undergo open femoral access.
Patients in whom the percutaneous method failed
were found to have small and/or tortuous iliac arter-
ies, underlying occlusive disease, heavily calcified
arteries, or difficulties related to the placement of the
device or closure of the suture. Patients being con-
sidered for this approach should, therefore, be select-
ed on the basis of an appropriate iliac artery caliber,
without significant tortuosity, calcification, or occlu-
sive disease. They should also have favorable anatomy
to allow rapid exposure of the common femoral
arteries (eg, absence of morbid obesity, lack of an ear-
lier surgical exposure of the femoral artery), in case
conversion to an open groin exposure is necessary.
The percutaneous approach will become more
commonplace as the era of minimally invasive aortic
aneurysm repair evolves. Newer generation devices
are smaller and more flexible, with designs that will
allow for easier traversal of tortuous arteries.
Percutaneous techniques are possible today, with
currently available technology. The future will
undoubtedly bring even smaller, more trackable
endograft introducer sheaths and more advanced
percutaneous arterial closure devices, which will
allow more patients to enjoy the benefits of a totally
percutaneous approach to aortic aneurysm repair.
REFERENCES
1. Zarins CK, White RA, Schwarten D, et al. AneuRx stent graft
versus open surgical repair of abdominal aortic aneurysms: mul-
ticenter prospective clinical trial. J Vasc Surg 1999;29:292-308.
2. May J, White GH, Yu W, et al. Concurrent comparison of
endoluminal versus open repair in the treatment of abdomi-
nal aortic aneurysms: analysis of 303 patients by life table
method. J Vasc Surg 1998;27:213-21.
3. Baim D, Pinkerton C, Vetter J, et al. Acute results of the
STAND II percutaneous vascular surgical device trial
[abstract]. Circulation 1997;96 Suppl I:I-442.
Table III. Detailed description of causes for percutaneous vascular closure failure
Patient number Failure type Reasons for failure
4 Bleeding Sutures caught on each other during fastening
5 Vessel dissection Heavily calcified and diseased iliac arteries; contralateral sheath upsized to 22F sheath
7 Device malfunction Arterial entry too steep
10 Vessel dissection Heavily calcified and diseased iliac arteries
12 Bleeding 24F sheath used for main body
15 Bleeding Suture of second device pierced first device suture; 24F sheath used for main body
16 Inflow Heavily calcified and diseased arteries; embolization
17 Bleeding Slip knot caught on loops of suture; 24F sheath used on main body
JOURNAL OF VASCULAR SURGERY
776 Traul et al October 2000
4. Gerckens U, Caatelaens N, Muller, et al. Percutaneous suture
of femoral artery access sites after diagnostic heart catheteri-
zation and or coronary intervention: safety and effectiveness
of a new arterial suture technique. Herz 1998;23:27-34.
5. Jordan WD Jr, Sampson LK, Iyer S, et al. Abdominal aortic
aneurysm repair via percutaneous endovascular stenting in
the swine model. Am Surg 1998;64:1070-3.
6. Papazoglou K, Christu K, Iordanides, et al. Endovascular
abdominal aortic aneurysm repair with percutaneous trans-
femoral prostheses deployment under local anesthesia: initial
experience with a new, simple-to-use tubular and bifurcated
device in the first 27 cases. Eur J Endovasc Surg 1999;17:202-
7.
7. Dietrich EB. In perspective: Endoluminal grafting, part I: what
do we need to know to achieve durable endoluminal abdominal
aortic aneurysm repair? Tex Heart Inst J 1997;24:179-84.
8. Haas PC, Kracjer Z, Dietrich EB. Closure of large percuta-
neous access sites using the Prostar XL percutaneous vascular
surgery device. J Endovasc Surg 1999;6:168-70.
Submitted Sep 29, 1999; accepted Mar 14, 2000.
TABLE OF CONTENTS BY E-MAIL
To receive the tables of contents by e-mail, sign up through our website at:
http://www.mosby.com/jvs
Choose E-mail Notification.
Simply type your e-mail address in the box and click the Subscribe button.
Alternatively, you may send an e-mail message to majordomo@mosby.com. 
Leave the subject line blank and type the following as the body of your message:
subscribe jvs_toc
You will receive an e-mail to confirm that you have been added to the mailing list. 
Note that TOC e-mails will be sent out when a new issue is posted to the website.
